✦ LIBER ✦

Phase II, Open-Label Trial of Single-Agent CCNU in Dogs with Previously Untreated Histiocytic Sarcoma

✍ Scribed by K.M. Rassnick; A.S. Moore; D.S. Russell; N.C. Northrup; O. Kristal; D.B. Bailey; A.B. Flory; M.A. Kiselow; J.L. Intile

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II open-label study of single-agen

✍ K. M. Rassnick; R. Al-Sarraf; D. B. Bailey; J. D. Chretin; B. Phillips; C. H. Zw 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 523 KB

An open-label, single-arm, phase 2 study

✍ Ravi Vij; David S. Siegel; Sundar Jagannath; Andrzej J. Jakubowiak; Alexander Ke 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

Retreatment of gefitinib in patients wit

✍ Oh, In-Jae; Ban, Hee-Jung; Kim, Kyu-Sik; Kim, Young-Chul 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 497 KB

A phase II open-label study of DHA-pacli

✍ Robert J. Jones; Robert E. Hawkins; Martin M. Eatock; David R. Ferry; Ferry A. L 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 265 KB

Pharmacokinetics and tolerability of sin

✍ Timothy Vollmer; Herbert R. Henney III 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 224 KB